• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD

ADALTA LIMITED - Charts / Financials

0.00% ! 0.3¢
Market Cap $2.516M  !
Healthcare Biotechnology
Add to My Watchlist

AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company... AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Day
Open 0.3¢   Day High 0.3¢   Day Low 0.3¢
Daily Volume 600000
Bids   Sellers
Number Price Volume   Number Price Volume
31 0.2¢ 24234107   11 0.3¢ 5352937

Directors & Senior Management

Dr. Timothy Oldham Chief Executive Officer, Managing Director, Executive Director
Dr. Michael Foley Chief Scientific Officer
Mr. Cameron Jones Company Secretary
Dr. Paul MacLeman Non-Executive Chairman of the Board
Ms. Michelle Burke Non-Executive Director
Dr. David Fuller Non-Executive Director
Mr. Iain Gladstone Ross Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $2.516M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.5K 600K

Buyers (Bids)

No. Vol. Price($)
31 24234107 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 5352937 11
View Market Depth
Last trade - 15.25pm 13/06/2025 (20 minute delay) ?

Top Stories

Week 24 Wrap: WW3 looms (again); US econ data tepid & silver surfing

By and large, I don't think I'd be without peers when I said the biggest thing that happened this week was on energy markets.
'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
Iberian expansion: Megado turns to Europe with Spanish copper mines Megado Minerals has added the Iberian Copper Project in Spain to its expanding collection after buying an 80% interest in Iberian Copper.
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.